Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
Sabela Bobillo, Pau Abrisqueta, Cecilia Carpio, Priyanka Raheja, Josep Castellví, Marta Crespo, Francesc Bosch
Haematologica December 2017 : haematol.2017.181636; doi:10.3324/haematol.2017.181636
Sabela Bobillo
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Pau Abrisqueta
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Cecilia Carpio
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Priyanka Raheja
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Josep Castellví
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Marta Crespo
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
Francesc Bosch
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain

Abstract
-
- Received October 3, 2017.
- Accepted December 7, 2017.
- Copyright © 2017, Ferrata Storti Foundation
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
Sabela Bobillo, Pau Abrisqueta, Cecilia Carpio, Priyanka Raheja, Josep Castellví, Marta Crespo, Francesc Bosch
Haematologica Dec 2017, haematol.2017.181636; DOI: 10.3324/haematol.2017.181636